by Elastomeric infusion pumps, also known as wearable infusion pumps, are medical devices that are primarily used for controlled drug delivery in home care settings. They offer several advantages over traditional syringe pumps such as portability, ease of use, and lower cost. Elastomeric pumps utilize controlled elastic pressure to continuously infuse fluids, nutrients, or medications into the patient’s body. Common applications include administration of chemotherapy drugs, antibiotics, pain medications, IV hydration, and total parenteral nutrition. The global market players offer a wide range of portable elastomeric pumps either as standalone devices or as part of infusion sets. With rapid technological advancements, these pumps are becoming smaller, more reliable, and integrated with smart features such as dose error reduction and automated alerts.
The global U.S. Elastomeric Infusion Pumps Market is estimated to be valued at US$ 288.59 Mn in 2023 and is expected to exhibit a CAGR of 5.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
Growing Demand for Home Care Infusion Therapy –
The increasing preference for home care therapy over hospitalization is a key driver boosting the demand for elastomeric infusion pumps in the United States. Home care infusion provides several benefits such as reduced healthcare costs, greater comfort, and convenience for chronic disease patients requiring long-term infusion. According to studies, home care infusion therapy is estimated to save 30-50% of costs compared to inpatient hospital stays. Various technological advancements making infusion devices more portable and low-maintenance are encouraging the shift to home care settings.
Introduction of Smart and Connected Pumps –
Major pump manufacturers are increasingly focusing on incorporating smart features such as electronic programming, dose error reduction technology, remote monitoring, and alerts to enhance safety, effectiveness, and user-experience. For instance, in 2022, Baxter International launched the Epiloc Smart Elastomeric pump with integrated connectivity, customizable infusion protocols, and remote programming capabilities. Such innovations are expected to drive the demand over the forecast period.
Segment Analysis:
The U.S. elastomeric infusion pumps market is dominated by the continuous ambulatory pumps sub-segment which holds around 62% share of the market. These pumps offer an ambulatory and portable method of drug delivery which makes them a preferred choice over traditional IV methods. They are a primary option for chronic disease management where patients require continuous infusion of drugs over extended periods of time at home.
PEST Analysis:
- Political: The market is largely regulated by the U.S FDA which sets stringent standards for approval and safety of medical devices. Changes in healthcare policies and coverage also impact industry growth.
- Economic: As the U.S faces rising healthcare costs, home healthcare is gaining prominence. Elastomeric pumps help avoid expensive hospital stays and support cost-effective chronic disease management.
- Social: With growing incidence of chronic diseases, managing healthcare needs at home is becoming a priority. Elastomeric pumps offer independence and flexibility for patients.
- Technological: Advancements focus on making pumps more compact, accurate and integrated with smart features. Connected pumps with remote monitoring capabilities are gaining popularity.
Key Takeaways:
The Global U.S. Elastomeric Infusion Pumps Market Demand is expected to witness high growth over the forecast period of 2023 to 2030. The global U.S. Elastomeric Infusion Pumps Market is estimated to be valued at US$ 288.59 Mn in 2023 and is expected to exhibit a CAGR of 5.7% over the forecast period 2023 to 2030.
The regional analysis indicates that the western region currently holds the largest market share mainly due to the high prevalence of chronic conditions however the northeast region is expected to grow at the fastest pace during the forecast period.
Key players operating in the U.S. Elastomeric Infusion Pumps are B. Braun Melsungen AG, Baxter International Inc., Werfen, Ambu A/S, Avanos Medical Inc., NIPRO, and Progressive Medical, Inc. B. Braun dominates the market with its wide range of elastomeric pumps for chemotherapy, analgesic delivery and post-surgical pain management. Baxter also has a significant presence with its ambulatory and continuous volumetric pumps.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
